Corbevax

Currently, Bharat Biotech's Covaxin, Serum Institute's Covishield and Covovax, Russian Sputink V and Biological E Ltd's Corbevax are listed in the CoWin portal.

Biological-E developing Omicron specific vaccine, contemplating it to be used as bivalent jab: Mahima Datla, CEO

The managing director of vaccine manufacturing company says regulatory framework along with financing and market predictability are important bottlenecks in developing variant specific vaccines against evolving coronavirus

COVID-19 booster dose drive fails to pick up, only one in five eligible adults jabbed

Meghalaya has the worst 8 percent coverage of the Covid booster dose among its eligible population, while Andhra Pradesh has the highest at 34 percent

Omicron sub-variant BA.2.75 dominant in Delhi; caution advised for those with low immunity, underlying diseases 

Sometimes referred to as the Centaurus, Omicron sub-variant BA.2.75 was first detected in May in India but has since been identified in at least 20 other countries

From August 12, option of Corbevax as booster doses for all jabbed with Covaxin, Covishield earlier

The recipients of Covaxin and Covishield, however, will also have an option of receiving the same vaccine they had taken for their primary vaccination

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.

Government nod for Corbevax as booster for adults vaccinated with Covishield, Covaxin soon

According to official sources, the Union health ministry will soon approve Biological E's Corbevax as a precautionary dose for adults who have received both Covishield and Covaxin vaccinations.

Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin

According to official sources, a government commission on Covid immunisation has advised enabling people who have received the complete course of either Covishield or Covaxin vaccination to take Biological E's Corbevax as a precautionary dose.

Political will at the top and community participation at the bottom drove India's COVID-19 vaccination campaign: Dr N K Arora

On July 17, India administered its 2 billionth COVID-19 vaccine dose, 18 months after the mammoth vaccination drive against coronavirus was launched. Of the total doses administered, 51 percent doses were given to women and 71 percent vaccination centres were in rural areas

Corbevax as booster dose after Covaxin, Covishield? Top panel on immunisation to discuss possibility

Last year, the Union government had paid an advance of Rs 1,500 crore to Corbevax maker Biological E to procure 30 crore doses of the vaccine, which was still in phase 3 clinical trials, in the first such deal to secure a vaccine.

Moneycontrol Selects: Top stories this evening

Our specially curated package of the most interesting articles to help you stay at the top of your game.

NTAGI's technical sub-committee recommends use of Corbevax, Covaxin for children between 5-12 years

Biological E’s Corbevax has been recommended for administration in 5 to 12 years old children, while the Bharat Biotech’s Covaxin has been recommended for children in 6-12 years’ age group.

Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin 

The pharma regulator has approved the first mix-and-match of COVID-19 vaccines in India, but the final say-so lies with the government 

Moneycontrol Daily: Your Essential 7

A daily round-up of the most interesting articles to help jump-start the day.

Moneycontrol Selects: Top stories this evening

Our specially curated package of the most interesting articles of the day will help you stay at the top of your game.

COVID-19 Vaccine | Corbevax gets DCGI nod as heterologous booster dose

COVID-19 Vaccine: With this, Corbevax becomes the first vaccine approved as a heterologous Covid-19 booster.

Covid-19: 10 crore doses of SII's Covovax approved for exports by govt lab, stock rolled out for teens

Covovax, the Covid-19 vaccine manufactured by the Serum Institute of India under licence from US firm Novavax, will be available at Rs 225 per dose, excluding taxes, at private healthcare facilities.

Exclusive: Supplied nearly 100 million doses to Govt; committed to meeting growing demand for Corbevax: Biological E’s COO

Data on the Omicron variant in children was not part of our clinical trial endpoints. We have submitted all the data generated against multiple variants to regulatory agencies including NTAGI. We are regularly making presentations to the regulatory bodies as more and more data gets generated, says Lakshminarayana Neti

Will wait for NTAGI’s nod before administering COVID-19 vaccine in 5-12 age group: Health Minister

When asked if the gap for taking the booster dose has been reduced from nine months to six, the minister said, NTAGI is the panel to take decisions in this regard.

COVID-19 vaccines for 5-11-year-olds may be limited to private hospitals 

Government approval for the administration of COVID-19 vaccines to children in the 5-11-year age group is possible as early as next week, according to health ministry officials familiar with the situation. 

Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away

Private healthcare providers struggling to use up their stocks of Covishield and Covaxin shots are showing no enthusiasm for the Corbevax vaccination of children.

Over 23,000 children aged 12-14 years received first dose of Corbevax vaccine

The Centre has asked states to organise dedicated Covid vaccination sessions through earmarked centres and train vaccinators to avoid mixing of vaccines during the inoculation of children in the 12-14 age group.

COVID-19 Vaccine | Govt to procure Corbevax at Rs 290 for two doses, private hospitals at Rs 800

On March 16, India began the inoculation drive for children aged 12 to 14 years, administering only the Corbevax COVID-19 vaccine to the beneficiaries.

COVID-19 | India begins vaccinating children aged 12-14 years

On March 16, the inoculation of children in the age group 12 to 14 against COVID-19 started with the administered Corbevax vaccine against COVID-19. Two doses of Biological E’s intramuscular Corbevax vaccine would be administered to the beneficiaries in an interval of 28 days.

COVID-19 vaccine for 12-14-year-olds to start from March 16; all above 60 years can take boosters

The new decision will mean that, while Corbevax will be offered to the younger adolescents, those in the 15-17-year age group will continue to get Covaxin.